{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:41:28Z","timestamp":1794332488630,"version":"4.9.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jchromb.2026.125107","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T16:29:47Z","timestamp":1778084987000},"page":"125107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Immobilized recombinant Fc\u03b3RIIIa and FcRn receptors as a tool for characterization of human IgG antibodies"],"prefix":"10.1016","volume":"1279","author":[{"given":"Lucija","family":"Don\u010devi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomislav","family":"Friganovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Grb\u010di\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko","family":"Filipovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Boro\u0161ak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sini\u0161a","family":"Habazin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordan","family":"Lauc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egbert","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djuro","family":"Josi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2026.125107_bb0005","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-15887-z","article-title":"A homogeneous bioluminescent immunoassay for parallel characterization of binding between a panel of antibodies and a family of Fc\u03b3 receptors","volume":"12","author":"Nath","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jchromb.2026.125107_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcoa.2025.100300","article-title":"Chromatography on monolithic supports for biological nanoparticles and large biomolecules: recent developments and state-of-the-art","volume":"9","author":"Friganovi\u0107","year":"2026","journal-title":"J. Chromatogr. Open"},{"key":"10.1016\/j.jchromb.2026.125107_bb0015","article-title":"Development of liquid chromatography on monolithic supports\u2014from first concepts to real analytical and preparative techniques","volume":"26","author":"Friganovi\u0107","year":"2025","journal-title":"IJMS"},{"key":"10.1016\/j.jchromb.2026.125107_bb0020","unstructured":"D. Josi\u0107, M. Begi\u0107, J. Simovi\u0107 Medica, Method of Purifying or Removing a Target Component from Full Plasma, EP 4223381 A1, 2023. https:\/\/patentimages.storage.googleapis.com\/60\/04\/86\/cbee133b4fa9aa\/EP4223381A1.pdf."},{"key":"10.1016\/j.jchromb.2026.125107_bb0025","unstructured":"D. Josi\u0107, M. Begi\u0107, U. Jelkovi\u0107, A Process for the Purification of Prothrombin Complex Concentrate (PCC) and FIX from Complete Plasma or Cryo-poor Plasma, US 2023\/0356110 A1, 2023. https:\/\/patents.justia.com\/patent\/20230356110."},{"key":"10.1016\/j.jchromb.2026.125107_bb0030","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1423-0410.2009.01226.x","article-title":"Intravenous immunoglobulin G: trends in production methods, quality control and quality assurance: intravenous immunoglobulin G","volume":"98","author":"Radosevich","year":"2010","journal-title":"Vox Sang."},{"key":"10.1016\/j.jchromb.2026.125107_bb0035","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","article-title":"American Society of Hematology 2019 guidelines for immune thrombocytopenia","volume":"3","author":"Neunert","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.jchromb.2026.125107_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2024.103710","article-title":"Intravenous immunoglobulin as a therapy for autoimmune conditions","volume":"24","author":"Danieli","year":"2025","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jchromb.2026.125107_bb0045","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/mus.27922","article-title":"Updated consensus statement: Intravenous immunoglobulin in the treatment of neuromuscular disorders report of the AANEM ad hoc committee","volume":"68","author":"Tavee","year":"2023","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jchromb.2026.125107_bb0050","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/art.42041","article-title":"2021 American College of Rheumatology\/Vasculitis Foundation Guideline for the Management of Kawasaki Disease","volume":"74","author":"Gorelik","year":"2022","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jchromb.2026.125107_bb0055","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2249.2009.04022.x","article-title":"Intravenous immunoglobulins \u2013 understanding properties and mechanisms","volume":"158","author":"Durandy","year":"2009","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jchromb.2026.125107_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2022.463518","article-title":"Extending the performance of FcRn and Fc\u03b3RIIIa affinity liquid chromatography for protein biopharmaceuticals","volume":"1682","author":"Bouvarel","year":"2022","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2026.125107_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00223","article-title":"Multiple variables at the leukocyte cell surface impact Fc \u03b3 receptor-dependent mechanisms","volume":"10","author":"Patel","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jchromb.2026.125107_bb0070","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJMra2312718","article-title":"Neonatal Fc receptor \u2014 biology and therapeutics","volume":"392","author":"Bussel","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jchromb.2026.125107_bb0075","doi-asserted-by":"crossref","DOI":"10.21037\/aob-20-59","article-title":"Intravenous immunoglobulins (IVIg) in childhood immune thrombocytopenia: towards personalized medicine\u2014a narrative review","volume":"6","author":"Schmidt","year":"2021","journal-title":"Ann. Blood"},{"key":"10.1016\/j.jchromb.2026.125107_bb0080","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cellimm.2018.07.009","article-title":"Immunoglobulin G glycosylation in aging and diseases","volume":"333","author":"Gudelj","year":"2018","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.jchromb.2026.125107_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jchromb.2026.125107_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1304365","article-title":"Impact of structural modifications of IgG antibodies on effector functions","volume":"14","author":"Damelang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jchromb.2026.125107_bb0095","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1016\/j.bbagen.2017.06.020","article-title":"IgG glycan patterns are associated with type 2 diabetes in independent European populations","volume":"1861","author":"Lemmers","year":"2017","journal-title":"Biochim. Biophys. Acta (BBA) \u2013 Gen. Subj."},{"key":"10.1016\/j.jchromb.2026.125107_bb0100","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/imr.13407","article-title":"The importance of IgG glycosylation\u2014what did we learn after analyzing over 100,000 individuals","volume":"328","author":"Kri\u0161ti\u0107","year":"2024","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jchromb.2026.125107_bb0105","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jim.2005.08.009","article-title":"IgG subclass-independent improvement of antibody-dependent cellular cytotoxicity by fucose removal from Asn297-linked oligosaccharides","volume":"306","author":"Niwa","year":"2005","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jchromb.2026.125107_bb0110","doi-asserted-by":"crossref","first-page":"15222","DOI":"10.18632\/aging.103884","article-title":"Global variability of the human IgG glycome","volume":"12","author":"\u0160tambuk","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.jchromb.2026.125107_bb0115","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/glycob\/cwv065","article-title":"Fc glycans of therapeutic antibodies as critical quality attributes","volume":"25","author":"Reusch","year":"2015","journal-title":"Glycobiology"},{"key":"10.1016\/j.jchromb.2026.125107_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139828","article-title":"Comparison of Fc N-glycosylation of pharmaceutical products of intravenous immunoglobulin G","volume":"10","author":"Fokkink","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jchromb.2026.125107_bb0125","doi-asserted-by":"crossref","first-page":"15865","DOI":"10.1021\/acs.chemrev.1c01031","article-title":"High-throughput glycomic methods","volume":"122","author":"Trbojevi\u0107-Akma\u010di\u0107","year":"2022","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jchromb.2026.125107_bb0130","doi-asserted-by":"crossref","first-page":"26733","DOI":"10.1074\/jbc.M202069200","article-title":"Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fc\u03b3RIII and antibody-dependent cellular toxicity","volume":"277","author":"Shields","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jchromb.2026.125107_bb0135","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41590-020-00828-7","article-title":"Proinflammatory IgG Fc structures in patients with severe COVID-19","volume":"22","author":"Chakraborty","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jchromb.2026.125107_bb0140","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nri2155","article-title":"FcRn: the neonatal Fc receptor comes of age","volume":"7","author":"Roopenian","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jchromb.2026.125107_bb0145","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1146\/annurev.immunol.18.1.739","article-title":"Multiple roles for the major histocompatibility complex class I-related receptor FcRn","volume":"18","author":"Ghetie","year":"2000","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jchromb.2026.125107_bb0150","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4049\/jimmunol.2200438","article-title":"IgG Fab glycans hinder FcRn-mediated placental transport","volume":"210","author":"Volkov","year":"2023","journal-title":"J. Immunol."},{"key":"10.1016\/j.jchromb.2026.125107_bb0155","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1126\/science.1129594","article-title":"Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation","volume":"313","author":"Kaneko","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.jchromb.2026.125107_bb0160","doi-asserted-by":"crossref","first-page":"E1297","DOI":"10.1073\/pnas.1422481112","article-title":"Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity","volume":"112","author":"Washburn","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jchromb.2026.125107_bb0165","doi-asserted-by":"crossref","first-page":"19571","DOI":"10.1073\/pnas.0810163105","article-title":"Identification of a receptor required for the anti-inflammatory activity of IVIG","volume":"105","author":"Anthony","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jchromb.2026.125107_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00197","article-title":"Differences in anti-inflammatory actions of intravenous immunoglobulin between mice and men: more than meets the eye","volume":"6","author":"Tjon","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jchromb.2026.125107_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.818382","article-title":"Enhanced immunomodulatory effect of intravenous immunoglobulin by Fc galactosylation and nonfucosylation","volume":"13","author":"Mimura","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jchromb.2026.125107_bb0180","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1080\/19420862.2019.1636602","article-title":"Glycoform-resolved Fc\u0263RIIIa affinity chromatography\u2013mass spectrometry","volume":"11","author":"Lippold","year":"2019","journal-title":"mAbs"},{"key":"10.1016\/j.jchromb.2026.125107_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2019.460554","article-title":"Fc\u03b3RIIIa chromatography to enrich a-fucosylated glycoforms and assess the potency of glycoengineered therapeutic antibodies","volume":"1610","author":"Freimoser\u2013Grundschober","year":"2020","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2026.125107_bb0190","doi-asserted-by":"crossref","first-page":"576","DOI":"10.4161\/mabs.24981","article-title":"Analytical FcRn affinity chromatography for functional characterization of monoclonal antibodies","volume":"5","author":"Schlothauer","year":"2013","journal-title":"mAbs"},{"key":"10.1016\/j.jchromb.2026.125107_bb0195","doi-asserted-by":"crossref","first-page":"26349","DOI":"10.1021\/acs.analchem.5c04766","article-title":"High-efficiency analytical protein A columns for high sensitivity monoclonal antibody titer analysis","volume":"97","author":"Muriithi","year":"2025","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2026.125107_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01299","article-title":"Adverse effects of immunoglobulin therapy","volume":"9","author":"Guo","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jchromb.2026.125107_bb0205","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1093\/ajhp\/zxac139","article-title":"Immune globulin therapy and kidney disease: overview and screening, monitoring, and management recommendations","volume":"79","author":"Kobayashi","year":"2022","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.jchromb.2026.125107_bb0210","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.neurol.2020.04.029","article-title":"Should we prevent thrombosis related to intravenous immunoglobulin infusions with systematic anticoagulant prophylaxis?","volume":"177","author":"Arcani","year":"2021","journal-title":"Rev. Neurol. (Paris)"},{"key":"10.1016\/j.jchromb.2026.125107_bb0215","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M111.010090","article-title":"High throughput isolation and glycosylation analysis of IgG\u2013variability and heritability of the IgG glycome in three isolated human populations","volume":"10","author":"Pu\u010di\u0107","year":"2011","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.jchromb.2026.125107_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003225","article-title":"Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers","volume":"9","author":"Lauc","year":"2013","journal-title":"PLoS Genet."},{"key":"10.1016\/j.jchromb.2026.125107_bb0225","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/gerona\/glt190","article-title":"Glycans are a novel biomarker of chronological and biological ages","volume":"69","author":"Kri\u0161ti\u0107","year":"2014","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.jchromb.2026.125107_bb0230","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-026-09789-3","article-title":"Integrative structural insights into the IgG-FcRn interactions revealed by engineered FcRn-immobilized affinity chromatography","author":"Kiyoshi","year":"2026","journal-title":"Commun. Biol."},{"key":"10.1016\/j.jchromb.2026.125107_bb0235","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1021\/acs.jproteome.6b00171","article-title":"LaCyTools: a targeted liquid chromatography\u2013mass spectrometry data processing package for relative quantitation of glycopeptides","volume":"15","author":"Jansen","year":"2016","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jchromb.2026.125107_bb0240","series-title":"High-Throughput Glycomics and Glycoproteomics","first-page":"31","article-title":"High-throughput analysis of IgG Fc glycopeptides by LC-MS","author":"Falck","year":"2017"},{"key":"10.1016\/j.jchromb.2026.125107_bb0245","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/nbt.2377","article-title":"A cross-platform toolkit for mass spectrometry and proteomics","volume":"30","author":"Chambers","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jchromb.2026.125107_bb0250","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1093\/bioinformatics\/btn323","article-title":"ProteoWizard: open source software for rapid proteomics tools development","volume":"24","author":"Kessner","year":"2008","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jchromb.2026.125107_bb0255","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-22199-8","article-title":"Assessing the heterogeneity of the Fc-glycan of a therapeutic antibody using an engineered Fc\u03b3 receptor IIIa-immobilized column","volume":"8","author":"Kiyoshi","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jchromb.2026.125107_bb0260","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00877","article-title":"Decoding the human immunoglobulin G-glycan repertoire reveals a spectrum of Fc-receptor- and complement-mediated-effector activities","volume":"8","author":"Dekkers","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jchromb.2026.125107_bb0265","doi-asserted-by":"crossref","DOI":"10.1002\/btpr.3304","article-title":"Fc\u03b3RIIIA affinity chromatography complements conventional functional characterization of rituximab","volume":"39","author":"Narvekar","year":"2023","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.jchromb.2026.125107_bb0270","doi-asserted-by":"crossref","first-page":"16513","DOI":"10.1021\/acsomega.3c02374","article-title":"Chromatographic analysis of the N-glycan profile on therapeutic antibodies using Fc\u03b3RIIIa affinity column chromatography","volume":"8","author":"Hiranyakorn","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.jchromb.2026.125107_bb0275","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2505473122","article-title":"Exploring glycoform-dependent dynamic modulations in human immunoglobulin G via computational and experimental approaches","volume":"122","author":"Yanaka","year":"2025","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jchromb.2026.125107_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e08030","article-title":"Low-pressure chromatographic separation and UV\/Vis spectrophotometric characterization of the native and desialylated human apo-transferrin","volume":"7","author":"Friganovi\u0107","year":"2021","journal-title":"Heliyon"}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023226001960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023226001960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:10:20Z","timestamp":1794330620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023226001960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":56,"alternative-id":["S1570023226001960"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2026.125107","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immobilized recombinant Fc\u03b3RIIIa and FcRn receptors as a tool for characterization of human IgG antibodies","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2026.125107","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"125107"}}